Daniel Chapman DO PharmD (He/Him)
Neuroimmunology/Multiple Sclerosis
Assistant Professor of Neurology
Join to View Full Profile
260 Stetson StreetSuite 2300Cincinnati, OH 45219
Dr. Chapman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Daniel Chapman, DO is a neurologist based in Cincinnati, OH, specializing in neuroimmunology and multiple sclerosis. He completed his neurology residency at the University of Cincinnati Medical Center and a fellowship in neuroimmunology and multiple sclerosis at Oregon Health & Science University. Dr. Chapman holds a DO from Oklahoma State University and a PharmD from Southwestern Oklahoma State University. He is currently an Assistant Professor at the University of Cincinnati Medical Center and has expertise in neurosarcoidosis, transverse myelitis, multiple sclerosis, and limbic encephalitis. His publications include works on polypharmacy in multiple sclerosis and diagnostic biomarkers in Alzheimer’s disease.
Education & Training
Oregon Health & Science UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2022 - 2023
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 2018 - 2022
Oklahoma State University Center for Health SciencesClass of 2018, DO
Southwestern Oklahoma State UniversityPharmD, 2008 - 2011
Certifications & Licensure
OH State License 2023 - 2027
KY State License 2023 - 2026
OK State License 2011 - 2025
OR State License 2022 - 2025
TX State License 2011 - 2016
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 3 citationsPolypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.W Daniel Chapman, Megan C Herink, Michelle H Cameron, Dennis Bourdette
Current Neurology and Neuroscience Reports. 2023-09-01
Journal Articles
- Diagnostic biomarkers in Alzheimer’s diseaseEmerlee Andersen a, Bryce Casteigne b, William Daniel Chapman b, Andrew Creed b, Forrest Foster b, Allison Lapins c, Rhonna Shatz b, Russell P. Sawyer, Biomarkers in Neuropsychiatry, 12/2021
- Why Children Fail the Test of Memory Malingering: Review of False Positive Performance in Pediatric StudiesAnya Mazur-Mosiewicz, A. I. Ford, W. D. Chapman, J. H. Crawford & M. C. Farabough, Journal of Pediatric Neuropsychology, 10/9/2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
